期刊文献+

冠心病合并慢性肾功能不全患者的临床特征和PCI远期预后分析 被引量:7

Clinical characteristics and long-term outcome of PCI in patients with chronic renal insufficiency
下载PDF
导出
摘要 目的测定冠心病合并慢性肾功能不全(CRI)患者的临床特征,并探讨药物洗脱支架对这些患者冠状动脉介入治疗(PCI)的主要不良事件发生率和临床远期预后的作用。方法973例经冠状动脉造影确诊冠状动脉明显狭窄(管腔内径减少>50%)中,516例合并肾功能不全(CRI组),457例肾功能正常(对照组)。记录两组基础临床和造影情况,每例均接受PCI治疗和术后临床随访。结果CRI组高龄、高血压及糖尿病患者明显多于对照组,但左室射血分数显著低于对照组。CRI组冠状动脉复杂病变(C型)明显多于对照组。平均17个月随访结果显示,CRI组总病死率高于对照组(6.2%和3.3%,P<0.05)。亚组分析显示,CRI患者药物洗脱支架治疗后病死率低于普通支架(4.1%和8.5%,P<0.05)。结论CRI患者通常冠状动脉病变严重,PCI后病死率明显增加,但药物洗脱支架较普通支架显著改善远期预后。 Objective To determine clinical characteristics and the effects of drug-eluting stents on the occurrence of major adverse cardiac events during percuteneous coronary artery interventional (PCI)and longterm outcomes in patients with chronic renal insufficiency (CRI). Methods Nine hundreds and seventy three patients with angiographically-documented coronary artery disease (lumen inner diameter narrowing 〉 50%), included 516 patients complicated with experienced renal impairment (CRI group)and 457 with normal renal function (control group). Baseline clinical data and coronary angiographic features were recorded. Results Comparing with control group, patients in CRI group were older with higher incidence of hypertension or diabetes and simultaneously complicated by reduced left ventricular ejection fraction, and more complex coronary lesions (type C). During follow-up(mean 17 months), the mortality was significantly higher in CRI than in control group (6.2% vs 3.3%, P 〈 0.05), but the former with CRI was significantly lower by using drug-eluting stents in comparing with bare-metal stents(4.1% vs 8.5%, P 〈 0.05). Conclusion Patients with CRI often complicated with severe coronary artery disease, the mortality after PCI would be significantly reduced by using drug-eluting stents.
出处 《介入放射学杂志》 CSCD 2007年第3期152-154,共3页 Journal of Interventional Radiology
关键词 慢性肾功能不全 冠心病 经皮冠状动脉介入术 Chronic renal insufflciency Coronary heart disease Percutaneous coronary intervention
  • 相关文献

参考文献4

二级参考文献25

  • 1倪钧,沈卫峰,张建盛,胡健,张奇,张宪,郑爱芳.Firebird药物洗脱支架治疗冠状动脉原发病变[J].介入放射学杂志,2004,13(5):396-398. 被引量:37
  • 2李光,周颖玲,陈纪言.雷帕霉素洗脱支架在冠心病患者中应用一年后的疗效[J].介入放射学杂志,2005,14(1):15-17. 被引量:10
  • 3张大东,冯小弟,陈跃光,肖红兵,金贤,杨晖,范筱敏,李伟华.国产药物洗脱支架的临床应用[J].介入放射学杂志,2005,14(3):236-238. 被引量:7
  • 4Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med,2002,346:1773-1780.
  • 5Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controller trial (E-SIRIUS). Lancet,2003,362:1093-1099.
  • 6Marx SO, Jayaraman T, Go LO, et al. Rapamycin-FKBP inhibits cell cycle regulators in vascular smooth muscle cells. Circ Res,1995,76:412-417.
  • 7Gregory C, Pratt R, Huie P, et al. Effects of treatment with cyclosporine, FK506, rapamycin, mycophenolic acid, or deoxyspergualin in vascular muscle proliferation in vitro and in vivo. Transplant Proc,1993,25:770-771.
  • 8Gregory C, Huie P, Shorthouse R, et al. Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury. Transplant Proc,1993,25:120-121.
  • 9Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med,1994,331:496-501.
  • 10Kornowski R, Hong MK, Haley L, et al. In-stent restenosis: contributions of inflammatory responses and arterial injery to neointimal hyperplasia. J Am Coll Cardiol,1998,31:224-230.

共引文献73

同被引文献48

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部